Pro Dex INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Pro-Dex, Inc. announced a 322% surge in net income and a 155% increase in backlog for fiscal year 2025, driven by strong medical device sales and the launch of a next-generation product.
NASDAQ
Pro-Dex, Inc. saw a 17% increase in revenue for fiscal year 2024, driven by growth in medical device sales and repairs, despite a significant decrease in backlog.